LATE BREAKING ABSTRACT: A phase 1 study of PF-06647020, an antibody-drugconjugate targeting PTK7, in patients with advanced solid tumors

Date 27 September 2015
Event European Cancer Congress 2015
Session Early Drug Development II
Topics Clinical Research
Basic Scientific Principles
Presenter Tolcher, A.